Logo

Richard Brennan

Jul 24, 2007
Premium
GeneGo has tapped Richard Brennan as director of toxicology, a role that will include running the MetaTox Consortium, a public/private systems biology collaborative, the company said last week.
 
Brennan previously was director of molecular and investigative toxicology at Iconix Biosciences, an associate director of pharmacology and cell biology at Cornerstone Pharmaceuticals, and a senior scientist at OSI Pharmaceuticals.

Filed under

Microarrays & Multiplexing
microarrays
Breaking News
The Scan

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.

Study Points to Benefits of Local Consolidative Therapy, Targeted Treatments in Cancer Care

In JCO Precision Oncology, researchers report that local consolidative therapy combined with molecularly targeted treatments could improve survival for some lung cancer patients.

Genetic Variants That Lower LDL Cholesterol Linked to Reduced Heart Disease Risk

Rare variants in two genes that lower LDL cholesterol are also associated with a decreased risk of coronary heart disease, according to a new JAMA Cardiology study.

Study Links Evolution of Longevity, Social Organization in Mammals

With the help of comparative phylogenetics and transcriptomics, researchers in Nature Communications see ties between lifespan and social organization in mammals.